A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)
Clinical trial NCT02497001 · COMPLETED
Trial details
- NCT number
- NCT02497001
- Sponsor
- Pearl Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-10
- Primary completion
- 2018-01-05
- Enrollment
- 1902
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.